Sally Hamry
Sally recently graduated with an MSc from the Department of Chemistry at McGill University where she used mass spectrometry to investigate natural product biosynthesis and protein conformational dynamics. As a science journalism intern at DDN, Sally has a passion for scientific storytelling and hopes to foster a greater understanding of science in multiple audiences. In her free time, you can find her making stained glass art, gardening, and exploring nature.
Articles by Sally Hamry
| 4 min read
A team of global scientists found an antibody-based therapeutic that they hope will stop the next rodent-borne hantavirus outbreak in its tracks.
| 3 min read
New inhibitors specific for gonorrhea enzymes may pave the way to treating multi-drug resistant infections.
| 3 min read
A bacterial inhibitor enhances conventional antibiotics by killing Staphylococcus aureus and stopping a communication system in Pseudomonas aeruginosa.
| 3 min read
Antibiotic resistance is on the rise and scientists are on the lookout for new therapeutics for treating human pathogens. One promising new venture repurposes antimalarial drugs to treat patients with chronic lung diseases such as cystic fibrosis.
Page 1 of 1 - 4 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Improving ALS research with pluripotent stem cell-derived models
Discover new advancements in modeling amyotrophic lateral sclerosis.
Automating 3D cell selection
Discover precise automated tools for organoid and spheroid handling.
A closer look at the tumor microenvironment
New technologies are allowing researchers to delve deeper into the complex tumor landscape.
